March 8, 2018 / 7:09 AM / 10 days ago

Sanofi, Evotec team up for research on infectious diseases treatment

PARIS (Reuters) - Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this area, led by Evotec.

FILE PHOTO: French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo

Sanofi will license its research into infectious diseases and its early-stage development portfolio, and the French group will also transfer its research unit dealing with this area over to Evotec.

Sanofi will pay Evotec an initial one-time cash upfront payment of 60 million euros ($74.4 million) and provide further significant long-term funding to develop portfolio, the companies added.

Reporting by Sudip Kar-Gupta; Editing by Gopakumar Warrier

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below